MedPath

An intervention study to prevent sarcopenia in hospitalized patients

Completed
Conditions
Type2 diabetes
Registration Number
jRCTs051190108
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients with type2 diabetes

Exclusion Criteria

Patients with type1 diabetes Steroid-treated patients Patients who received gastrectomy, pancreatectomy, or intestinal resection Patients who is difficult to be assessed muscle strength because of neuromuscular disease Somatostatin analog-treated patients Patients with hypothalamus or pituitary disease Patients who restrict protein intake because of kidney disease Patients who have difficulty of food intake or ingestion Patients with dementia Patients who restrict exercise Patients whose ADL (Activity of Daily Living) is weakened Unsuitable patients

Study & Design

Study Type
Interventional
Study Design
parallel assignment
Primary Outcome Measures
NameTimeMethod
-

Decline of muscle mass during hospitalization

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.